Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovaMin dentifrice for tooth sensitivity during bleaching
NCT06608368Phase 4Completed
- Sponsor
- Haleon
- Start
- Oct 2024
- Primary completion
- Nov 2024
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of calcium sodium phosphosilicate in dentin hypersensitivity (DH), sponsored by Haleon. Started Oct 2024; status: completed.
02
Drugs
calcium sodium phosphosilicate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06608368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608368.